CD4 and neoplasm: In classic Hodgkin’s Lymphoma, where MHC-I expression is lost but MHC-II expression is intact, CD4+ T cell infiltration in tumor was correlated with better prognosis in patients and showed improved efficacy of a PD-1 blocking antibody in MHC-II-expressing lymphoma.